期刊信息查詢系統

期刊標題檢索 LETT DRUG DES D 最新評論: Hello, have you followed up on the final submission? Have you recorded... (2024-07-18)

讓學術交流變得簡單

發布您的作品並從國際研究社群獲取反饋

APA 與 LetPub 合作，為作者提供全方位服務

[Letters in Drug Design & Discovery]您好，您是該頁面的第 41388 位訪客。

期刊簡介

期刊名稱

Letters in Drug Design & Discovery
LetPub Score

5.1

50 ratings

Rate

Reputation

6.4

Influence

3.7

Speed

7.0

期刊簡稱

LETT DRUG DES DISCOV

ISSN

1570-1808

E-ISSN

1875-628X

h-index

CiteScore

SJR

SNIP

CiteScore Rank

1.80

0.222

0.364

Subject field	Quartiles	Rank	Percentile
Category: Pharmacology, Toxicology and Pharmaceutics Subcategory: Pharmaceutical Science	Q3	107 / 183
Category: Pharmacology, Toxicology and Pharmaceutics Subcategory: Drug Discovery	Q4	125 / 157
Category: Pharmacology, Toxicology and Pharmaceutics Subcategory: Molecular Medicine	Q4	154 / 178

自引率 (2023-2024)

8.30%自引率趨勢

掲載範囲

Aims & Scope

Letters in Drug Design & Discovery publishes letters, mini-reviews, highlights and guest edited thematic issues in all areas of rational drug design and discovery including medicinal chemistry, in-silico drug design, combinatorial chemistry, high-throughput screening, drug targets, and structure-activity relationships. The emphasis is on publishing quality papers very rapidly by taking full advantage of latest Internet technology for both submission and review of manuscripts. The online journal is an essential reading to all pharmaceutical scientists involved in research in drug design and discovery.

官方網站

http://benthamscience.com/journal/index.php?journalID=lddd

在線稿件提交

http://benthamscience.com/journals/letters-in-drug-design-and-discovery/submit-abstracts-online/#top

開放訪問

出版商

Bentham Science Publishers B.V.

主題領域

医学

出版國/地區

UNITED STATES

發行頻率

隔月刊行

創刊年

2004

每年文章數

183每年文章數趨勢

黃金OA百分比

1.10%

Web of Science 四分位
（ 2023-2024）

WOS Quartile: Q4

Category	Edition	JIF Quartile	JIF Ranking	JIF Percentage
CHEMISTRY, MEDICINAL	SCIE	Q4	66/72

索引 (SCI or SCIE)

Science Citation Index Expanded

鏈接到PubMed Central (PMC)

https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1570-1808%5BISSN%5D

平均審稿時間 *

來自出版商的數據:
來自作者的數據: About 3.0 month(s)

競爭力 *

來自作者的數據: Easy

參考鏈接

相關期刊	【Letters in Drug Design & Discovery】CiteScore趨勢
自引率趨勢	每年文章數趨勢
作者評論

*所有的審稿過程指標，如接受率和審稿速度，僅限於用戶提交的稿件。因此，這些指標可能無法準確反映期刊的競爭力或速度。

同一學科的期刊
CiteScore趨勢
自引率趨勢
每年文章數趨勢

學科內的可信期刊	影響因子
JOURNAL OF MEDICINAL CHEMISTRY	H-index: 240 CiteScore: 12.80
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY	H-index: 135 CiteScore: 11.70
Marine Drugs	H-index: 84 CiteScore: 9.60
MINI-REVIEWS IN MEDICINAL CHEMISTRY	H-index: 79 CiteScore: 7.80
CURRENT TOPICS IN MEDICINAL CHEMISTRY	H-index: 104 CiteScore: 6.40
MEDICINAL CHEMISTRY RESEARCH	H-index: 38 CiteScore: 4.70
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS	H-index: 133 CiteScore: 5.70
Medicinal Chemistry	H-index: 39 CiteScore: 4.30
NATURAL PRODUCT RESEARCH	H-index: 42 CiteScore: 5.10
Records of Natural Products	H-index: 24 CiteScore: 3.10

學科內最受檢索的期刊	頁面查看次數
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY	289357
JOURNAL OF MEDICINAL CHEMISTRY	282294
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS	156898
NATURAL PRODUCT RESEARCH	152744
Marine Drugs	151846
MEDICINAL CHEMISTRY RESEARCH	56718
CURRENT TOPICS IN MEDICINAL CHEMISTRY	49794
Medicinal Chemistry	49069
MINI-REVIEWS IN MEDICINAL CHEMISTRY	38067
Records of Natural Products	33280

明年預測:
穩步上升無變化逐步下降　刷新

首頁上一頁 1 下一頁末頁 (頁 /1)
[Letters in Drug Design & Discovery] 的評論	撰寫評論

作者: 亮度領域: 医学審稿時間: 0.0 month(s) 結果: 待定＆不明撰寫評論	2024-07-18 01:29:06 評論於 Hello, have you followed up on the final submission? Have you recorded it now? (0) 讚！ \| 亮度
作者: 乐观領域: 化学審稿時間: 0.0 month(s) 結果: 待定＆不明撰寫評論	2023-05-18 00:17:21 評論於 Hello, I would like to ask who should the reminder letter be sent to? There is no email address for the editor. (0) 讚！ \| 乐观
作者: 匿名領域: 審稿時間: 0.0 month(s) 結果: 撰寫評論	2011-08-20 17:16:00 評論於 Journal Homepage URL: http://www.benthamscience.com/lddd/ (0) 讚！ \| 匿名
作者: 匿名領域: 審稿時間: 0.0 month(s) 結果: 撰寫評論	2010-11-08 20:53:00 評論於 There are three reviewers and they ask a lot of questions. They agreed to refuse the article, but the editor encouraged acceptance with revisions. I think there is hope after the overhaul. (0) 讚！ \| 匿名

首頁上一頁 1 下一頁末頁 (頁 /1)

開始撰寫 [Letters in Drug Design & Discovery] 的評論：

您的評論將是選擇期刊的重要參考信息。歡迎分享您的投稿經驗！
研究領域:
接受狀態:	審稿時間: 個月以內
您的評論:
姓名:	(建議: 請輸入有效的電子郵件地址以便與審稿者互動，或註冊LetPub帳戶。)
給管理員留言:	我的評論包含修正信息如果您發現該期刊頁面中有錯誤的信息或希望提供額外內容，請勾選此框。管理員將檢查並儘快更新期刊說明。
隨機碼:	點擊刷新

期刊名稱:	ISSN:	主題領域:	影響因子範圍: -
索引:	類別:	開放訪問:	排序方式:

作者: 亮度領域: 医学審稿時間: 0.0 month(s) 結果: 待定＆不明撰寫評論	2024-07-18 01:29:06 評論於 Hello, have you followed up on the final submission? Have you recorded it now? (0) 讚！ \| 亮度
作者: 乐观領域: 化学審稿時間: 0.0 month(s) 結果: 待定＆不明撰寫評論	2023-05-18 00:17:21 評論於 Hello, I would like to ask who should the reminder letter be sent to? There is no email address for the editor. (0) 讚！ \| 乐观
作者: 匿名領域: 審稿時間: 0.0 month(s) 結果: 撰寫評論	2011-08-20 17:16:00 評論於 Journal Homepage URL: http://www.benthamscience.com/lddd/ (0) 讚！ \| 匿名
作者: 匿名領域: 審稿時間: 0.0 month(s) 結果: 撰寫評論	2010-11-08 20:53:00 評論於 There are three reviewers and they ask a lot of questions. They agreed to refuse the article, but the editor encouraged acceptance with revisions. I think there is hope after the overhaul. (0) 讚！ \| 匿名

首頁上一頁 1 下一頁末頁 (頁 /1)

Letters in Drug Design & Discovery

期刊標題檢索 LETT DRUG DES D 最新評論: Hello, have you followed up on the final submission? Have you recorded... (2024-07-18)

[Letters in Drug Design & Discovery]您好，您是該頁面的第 41388 位訪客。

開始撰寫 [Letters in Drug Design & Discovery] 的評論：

Contact us